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ROSETTAGCAPs are neuronal Ca2+-sensors playing a central role in light adaptation. GCAPs are N-terminally myristoylated
membrane-associated proteins. Although, the myristoylation of GCAPs plays an important role in light adaptation
its structural and physiological roles are not yet clearly understood. The crystal-structure of GCAP-1 shows the
myristoyl moiety inside the hydrophobic core of the protein, stabilizing the protein structure; but 2H-solid-state
NMR investigations on the deuterated myristoyl moiety of GCAP-2 in the presence of liposomes showed that it
is inserted into the lipid bilayer. In this study, we address the question of the localization of the myristoyl group
of Ca2+-bound GCAP-2, and the influence of CHAPS-, DPC-micelles and DMPC/DHPC-bicelles on the structure,
and on the localization of themyristoyl group, of GCAP-2 by solution-state NMR.We also carried out the backbone
assignment. Characteristic chemical shift differences have been observed between themyristoylated and the non-
myristoylated forms of the protein. Our results support the view that in the absence of membrane forming
substances the myristoyl moiety is buried inside a hydrophobic pocket of GCAP-2 similar to the crystal structure
of GCAP-1. Addition of CHAPS-micelles and DMPC/DHPC-bicelles cause specific structural changes localized in
and around the myristoyl binding pocket. We interpret these changes as an indication for the extrusion of the
myristoyl moiety from its binding pocket and its insertion into the hydrophobic interior of the membrane
mimic. On the basis of the backbone chemical shifts, we propose a structural model of myristoylated GCAP-2 in
the presence of Ca2+ and membrane mimetics.lammonio]-1-propanesulfonate;
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Guanylate cyclase-activating proteins (GCAPs) are neuronal Ca2+-
sensors playing a central role in light adaptation through the Ca2+-
dependent regulation of the retinal guanylate cyclase. They belong to
the superfamily of calmodulin-like four EF hand Ca2+ binding proteins,
whereas the first EF hand is not able to bind Ca2+ [1,2].GCAPs are N-terminally myristoylated, membrane-associated pro-
teins [3]. Although, the myristoylation of GCAP plays an important
role in light adaptation [4–6] its structural and physiological roles are
not yet clearly understood. The myristoyl moiety can in principle be
buried inside the hydrophobic core or in a hydrophobic pocket of the
protein, where it may exert a structure-stabilizing function as shown
for the poliovirus VP4 protein [7] and the protein kinase A [8]. But
more frequently, lipid modifications serve as membrane anchors and
are consequently exposed to the surrounding medium [9–11] at least
upon membrane binding.
A switchmechanism from a protein embedded to a solvent exposed
or membrane inserted myristoyl chain has been shown for the closely
related proteins recoverin [12], neurocalcin δ [13], and hippocalcin
[14]. In these examples, the lipid modified soluble proteins are found
in two states. State I represents the soluble form, where the lipid mod-
ification is buried within the hydrophobic interior, and state II is the
membrane bound form, in which the lipid chain is released from the
protein interior and inserted into the lipid membrane. Such a mecha-
nism is best described for recoverin, where highly resolved structures
of both states have been solved by solution NMR spectroscopy [15].
For recoverin, the two states are controlled by the intracellular Ca2+
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myristoyl switch mechanism. The Ca2+-free form of recoverin has
the myristoyl moiety buried inside the hydrophobic core, but Ca2+-
binding leads to the exposure of the myristoyl moiety and hence to
the membrane binding of the protein [12,15–18].
Additionally, in the case of GCAPs, the myristoyl moiety could also
function as an activator for the guanylate cyclase through an interaction
with a dedicated binding site. In agreement with this assumption,
myristoylated GCAPs are better activators than the non-myristoylated
ones and myristoylated GCAP-1 has a sevenfold higher affinity for the
guanylate cyclase than non-myristoylated GCAP-1 [4].
Currently, only the structures of Ca2+-bound, non-myristoylated
GCAP-2, solved by solution-state NMR spectroscopy [19], Ca2+-bound,
myristoylated GCAP-1 [20] and Ca2+-bound, non-myristoylated
GCAP-3 [21] solved by X-ray crystallography, are available. The crystal
structure of myristoylated GCAP-1 shows the myristic acid inside the
hydrophobic core of the protein; therefore, the authors postulated a
structure-stabilizing function of the myristic acid [20]. In contrast,
Vogel et al. performed 2H solid-state NMR investigations on the deuter-
atedmyristoylmoiety of Ca2+-freeGCAP-2 in the presence of liposomes
and demonstrated that the myristoyl moiety is inserted into the lipid
bilayer of the membrane [22].
Both studies provide some insights with regard to the localization
and the functional role of the myristoyl moiety of GCAP-2, even if they
appear contradictory at first sight. However, there are relevant differ-
ences in these studies: first, the crystal structure shows GCAP-1 [20]
but Vogel et al. investigated GCAP-2 [22]. Despite the close relationship
and relatively high homology, the role of the myristoyl moiety could be
different for both isoforms. Second, the environment in a protein crystal
differs significantly from that in solution and is again very different from
the conditions at the membrane surface. It is possible that the tight
packing in the crystal forces the myristic acid inside the protein as a
requirement for the crystallization to occur. As a free lipid chain
acquires high mobility to reduce the free energy through an increase
in the configurational entropy [9,23,24], highly mobile (side) chains
typically represent a barrier for crystallization. Furthermore, the crystal
structure represents the Ca2+-bound state, whereas Vogel et al. investi-
gated the Ca2+-free form [22]. Therefore, it could be possible, that
an ‘inverse’ Ca2+-myristoyl switch mechanism (opposite to that of
recoverin) is present, such that in the Ca2+-bound state the myristic
acid is buried inside the hydrophobic core of the protein, but in the
Ca2+-free state the myristoyl moiety is released and inserted into
the membrane. Most reports interpret their data against a Ca2+-
myristoyl-switch, but some claim that they cannot exclude it [5,6,25,
26]. In biophysical studies, we confirmed, that the myristic moiety is
indeed inserted into the membrane in the Ca2+-free as well as in the
Ca2+-bound state [27], again finding no evidence for an inverse
myristoyl switch. Based on these data, however, we proposed a dif-
ferent model, according to which soluble GCAP-2 protein features
the myristoyl moiety sequestered inside a hydrophobic binding site
of the protein, upon membrane binding the high local concentration
of lipids favors and triggers the insertion of themyristoyl moiety into
the lipid bilayer.
In this study, we first address the question of the localization of the
myristoyl group of GCAP-2 in solution. Then, we study if a membrane-
like environment induces structural alterations of the protein that
would suggest a translocation of the myristoyl moiety from the protein
interior into the hydrophobic interior of a membrane. To address these
question by solution NMR, we studied structural alterations of GCAP-2
in the presence of the non-denaturing micelle-forming detergent
CHAPS, the detergent DPC, carrying the same head group as the main
phospholipids, and DMPC/DHPC bicelles as the most membrane-like
structures amenable to solution-state NMR. As a prerequisite for
this analysis, we carried out the NMR assignment of the backbone of
myristoylated GCAP-2 and determined a structuralmodel of the protein
using CS-ROSETTA [28].2. Material and Methods
2.1. Materials
Dodecylphosphocholine-d38, 15NH4Cl and D-glucose (U-13C, 99%)
were purchased from Cambridge Isotope Laboratories (Andover,
USA). 1,2-Diheptanoyl-sn-glycero-3-phosphocholine (DHPC) and 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC) were purchased
from Avanti Polar Lipids Inc. (Alabaster, USA). All other chemicals
were purchased from Carl Roth GmbH & Co KG (Karlsruhe, Germany),
Fluka-Chemie AG (Buchs, Switzerland), Merck KGaA (Darmstadt,
Germany) or Sigma-Aldrich Chemie GmbH (Deisenhofen, Germany)
with the highest possible degree of purity.
2.2. Protein production and preparation
GCAP-2 was produced in a fed-batch fermentation process by
heterologous expression in Escherichia coli BL21(DE3) carrying a pET-
11a expression vector encoding for bovine GCAP-2 and the plasmid
pBB131 encoding for the yeast N-myristoyl transferase I, enabling the
bacterial cells to perform this eukaryotic post-translationalmodification
[4,5,29]. As defined salt medium, a slightly modified version of the
medium described in [30] was used. The final composition was 10 -
20 g glucose, 3.2 g/l NH4Cl, 13.3 g/l KH2PO4, 4.3 g/l Na2HPO4, 1.2 g/l
MgSO4 · 7 H2O, 1.7 g/l citrate · H2O, 8.4 mg/l EDTA, 2.5 mg/l CoCl2 ·
6 H2O, 1.5 mg/l CuCl2 · 2 H2O, 3.0 mg/l H3BO3, 2.5 mg/l Na2MoO4 ·
2 H2O, 13.0 mg/l Zn(CH3COO)2 · 2 H2O, 100.0 mg/l Fe(III)citrate · H2O
with a pH of 6.7, for 15 N-labeling 15NH4Clwas used and for 13C-labeling,
the citrate was omitted and uniformly 13C-labeled glucose was used.
The pH (6.7) and the temperature (37 °C) were kept constant during
the entire fermentation process. The oxygen level was held above 30%
and the foam production was suppressed by adding Antifoam 204.
Glucose and NH4Cl were fed as needed. Myristoylation was achieved
by adding myristic acid (50-100 g/l in ethanol) to the growth medium
(final concentration ~100 mg/l) 30 min before and after induction
with IPTG. The cells were harvested by centrifugation (7459 RCF,
30 min, 4 °C) 4 h after induction. The biomass was resuspended
(1 g wet-weight biomass / 10 ml buffer) in inclusion body buffer 1
(100 mM Tris/HCl pH 8.0, 1 mM EDTA) and after addition of 10 mg
lysozyme for 1 h stirred and incubated on ice. The cells were then
disrupted using a French-press (3 passages, 1000 bar) and afterwards
incubated for 1 h at room temperature with 3 mM MgCl2 and 10 mg
DNase added. The inclusion bodies were separated by centrifugation
(38420 RCF, 25 min, 4 °C) and then washed at least 2 times with inclu-
sion body buffer 2 (100 mM Tris/HCl pH 7.0, 20 mM EDTA). They were
afterwards incubated (1 g wet-weight / 10 ml buffer) for at least 2 h in
solubilization buffer (100 mM Tris/HCl pH 8.0, 6 M guanidinium/HCl,
100mMDTT, 1mMEDTA) and so dissolved (final protein concentration
10 - 20 mg/ml). 10ml of this mixture were then slowly dropped into 1 l
of fast stirring ion exchange buffer (20mMTris/HCl pH 8.0, 1mMCaCl2,
1 mM DTT) and afterwards the solution was centrifuged (38420 RCF,
25 min, 4 °C) and filtered (cellulose nitrate filter from Satorius AG,
Göttingen, Germany) to remove the precipitates. Then, the solution
was loaded onto two HiTrap Q HP 5 ml ion-exchange columns (from
Amersham Pharmacia Biotech, Freiburg, Germany) equilibrated with
ion exchange buffer and the GCAP-2 was eluted by step elution (using
the ion exchange bufferwith 400mMNaCl added). The protein solution
was thendialyzed against storage buffer (20mMNa2HPO4 pH7.0, 1mM
DTT), frozen in liquid nitrogen and stored at -80 °C or diluted and
directly used for reversed-phase HPLC to separate myristoylated from
non-myristoylated GCAP-2. The VP 250/16 NUCLEOSIL 300-5 C18
column (fromMacherey-Nagel, Düren, Germany) was first equilibrated
(3.418 ml/min flow) to 99% deionised water (+0.1% TFA) and 1%
acetonitril, then 4 ml of protein solution were loaded in 1.5 min onto
the column and then eluted by a step to 41% acetonitril followed by
a linear gradient of 6 min to 61% acetonitril and a final step to 100%
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myristoylated (~77%) at ~11.5 min. The success of RP-HPLC was con-
trolled by SDS-PAGE andMALDI-TOF mass spectrometry. The appropri-
ate elution fractions were then lyophilized and afterwards redissolved
by incubating and shaking for at least 2 h in solubilization buffer
(max. 10 mg/ml) at room temperature. Then, the protein was refolded
again, by slowly dropping 5 - 7.5 ml of this solution into 500 ml of fast
stirring refolding buffer (100 mM Tris/HCl pH 8.0 - 8.5, 500 mM
Na2SO4, 1 mM DTT, 0.1 mM CaCl2) with a final protein concentration
of 100 - 150 μg/ml. No precipitationwas observed. Afterwards, the solu-
tion was concentrated below 50 ml by ultrafiltration (using a PLGC
10 kDa MWCO membrane from Millipore, Billerica, USA), extensively
dialyzed against the final buffer (20 mM MES pH 6.0, 10 mM CaCl2,
2 mM TCEP) and then concentrated by centrifugal ultrafiltration
(using an Amicon ultra centrifugal filter device with 5 – 10 kDa
MWCO from Millipore, Billerica, USA) to the final volume of 500 μl
(with a protein concentration between 200 - 900 μM). Just before mea-
suring, 25 μl of D2O were added for the lock signal.
2.3. Preparation of bicelles
DMPC/DHPC bicelles with q = 0.25 [31] were prepared by mixing
33.4 mg of DMPC (1,2-dimyristoyl-sn-glycero-3-phosphocholine) with
96.3 mg of DHPC (1,2-diheptanoyl-sn-glycero-3-phosphocholine) and
adding 500 μl of buffer (20 mMMES pH 6.0, 10 mM CaCl2, 2 mM TCEP).
The mixture was then incubated for 30 min at room temperature and
mixed by vortexing. Afterwards the mixture was incubated on ice for
30 min and then, while gently shaking, incubated at 42 °C for again
30min. This stepwas repeated at least 3 times until the solutionwas clear.
2.4. NMR spectroscopy and assignment
All NMR spectrawere recorded on Bruker DRX 600MHz and Avance
III 600 MHz spectrometers (Bruker, Rheinstetten, Germany) using
either a 5-mm-TBI or a 5-mm-TXI probehead with z-gradient. All 1H-
15 N HSQC spectra were recorded at 50 °C using the standard pulse
program [32]. For each titration step a 1H-15 N HSQC experiment,
using a relaxation delay of 0.8 s and the following acquisition parame-
ters, was recorded: for CHAPS titration (15 N: 192 data points, 61 ms
acquisition; 1H: 4096 data points, 213 ms acquisition), for DPC titration
(15 N: 256 data points, 81 ms acquisition; 1H: 4096 data points, 213 ms
acquisition), for DMPC/DHPC titration (15 N: 128 data points, 41 ms
acquisition; 1H: 4096 data points, 213ms acquisition). For the backbone
assignment, standard HNCO, HN(CA)CO, HNCA, HN(CO)CA triple reso-
nance 3D spectra [33] were recorded using a relaxation delay of 1 s
andwith the recommended values for the number of scans, data points,
and acquisition times: HNCO (number of scans (NS): 16; 13C: 169.5 -
178.5 ppm, 128 data points, 47 ms acquisition; 15 N: 106 - 132 ppm,
72 data points, 23ms acquisition; 1H: -3.5 - 12.5 ppm, 3072 data points,
160ms acquisition), HN(CA)CO (NS: 32; 13C: 169.5 - 178.5 ppm, 76 data
points, 28ms acquisition; 15 N: 106 - 132 ppm, 72 data points, 23ms ac-
quisition; 1H: -3.4 - 12.6 ppm, 3072 data points, 160 ms acquisition),
HNCA (NS: 16; 13C: 36 - 68 ppm, 96 data points, 10 ms acquisition;
15 N: 106 - 132 ppm, 72 data points, 23 ms acquisition; 1H: -3.2 -
12.8 ppm, 3072 data points, 160 ms acquisition), HN(CO)CA (NS: 24;
13C: 36 - 68 ppm, 104 data points, 11 ms acquisition; 15 N: 106 -
132 ppm, 72 data points, 23 ms acquisition; 1H: -3.2 - 12.8 ppm, 3072
data points, 160 ms acquisition).
For the titration experiments, a CHAPS, DPC, or bicelle stock solution
was prepared in the same buffer as the protein sample, and stepwise
titrated into the protein sample. As a measure for the structural influ-
ences of the titrated substance the weighted chemical shift difference
Δδ [34] was calculated:
Δδ ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ΔδHð Þ2 þ ΔδN=5ð Þ2
q
ð1Þ(ΔδX: difference of chemical shift in the X dimension given in ppm). A
difference of 0.02 ppm [35] or 0.04 ppm [36] is commonly considered
as significant.
2.5. CS-ROSETTA modeling
The homology model of myristoylated Ca2+ bound GCAP-2 was
constructed based on the crystal structure of GCAP-1 (PDB ID: 2R2I,
[20]). It was then refined leveraging the measured back bone chemical
shifts (HN, NH, C’ and Cα) and using CS-ROSETTA [28,37]. Briefly: A
total of 14,500 differentmodels were created using a loopmodeling ap-
proach and relaxation protocol. Loops ranged from residues 3-22, 34-40,
48-54, 119-145 and 189-203, excluding only the EF hand residues. The-
oretical chemical shifts for all generated models were predicted using
Sparta + [50] and the original CS-ROSETTA scoring function was used.
A detailed protocol capture of the modeling process can be found in
the supplementary information.
3. Results
3.1. Assignment and secondary structure of myristoylated GCAP-2
As a prerequisite for the investigation of the interaction of
myristoylated GCAP-2 with lipid surfaces by solution-state NMR, we
carried out the backbone assignment of the Ca2+-bound myristoylated
form of the protein. Because of the higher quality of the 3D triple reso-
nance NMR spectra, the assignment was carried out at 50 °C and in
the presence of 10 mM CHAPS. Under these conditions, we were able
to assign ~84% of all backbone signals unambiguously. A 1H-15 N HSQC
NMR spectrum of myristoylated GCAP-2 with the signal assignments
is shown in Fig. 1
Using TALOS+ [37] the secondary structure ofmyristoylated GCAP-
2 was predicted from the measured chemical shifts of the backbone
signals (Cα, C’, NH, HN). The result of this analysis is shown in Fig. 2.
For comparison, the secondary structure of Ca2+-bound non-
myristoylated GCAP-2 [19] is also shown schematically. Similar to the
non-myristoylated form and not surprisingly, myristoylated GCAP-2
shows four EF-hands. We could also identify the flexible loop compris-
ing amino acids 129-146, which represents a main difference between
GCAP-1 and GCAP-2. In addition, the termini of the protein were deter-
mined to be unstructured in the presence of 10 mM CHAPS. The
N-terminus shows the only relevant difference between our secondary
structure for the myristoylated form (determined from the backbone
chemical shifts with TALOS+) and the secondary structure of non-
myristoylated GCAP-2 (determined by [19]). In our preparation of
myristoylatedGCAP-2,we could notfindany indication for thepresence
of the short N-terminal helix described in the literature [19]. Our result
is also in agreement, with previous solid-state NMR investigations of a
short membrane bound N-terminal peptide of GCAP-2, where this
short helix could also not be confirmed [38].
3.2. Influence of the myristoyl moiety on the protein structure
Alterations in the chemical shifts (especially for 15NH and 1HN) are a
sensitive indicator for structural changes of a protein. We investigated
the structural influence of the myristoyl moiety by comparing the
chemical shifts of the backbone signals in the 1H-15 N HSQC spectra of
myristoylated and non-myristoylated GCAP-2 under the exact same
buffer conditions (20 mMMES pH 6.0, 10 mM CaCl2, 2 mM TCEP) and
comparable protein concentrations (~250 μM). The NMR spectra are
shown in Fig. S1. Because of the strong influence of the attachment of
the myristoyl moiety on the chemical shift of many signals, a transfer
of the assignment to the non-myristoylated form was unambiguous
for only ~56% of all backbone signals. Fig. 3 shows the weighted chem-
ical shift difference Δδ (see Eq. (1) [35,36]) between the myristoylated
and the non-myristoylated forms of GCAP-2 as a measure for the
Fig. 1. 1H-15 N HSQC spectrum of myristoylated GCAP-2 and assignment of ~84% of the backbone signals (by residue number). The sample contained 200 μMmyristoylated GCAP-2 in
500 μl buffer (20 mM MES pH 6.0, 10 mM DTT, 10 mM CaCl2, 10 mM CHAPS) with 25 μl D2O added for the lock signal. Trp side chains signals are marked with an asterisk (*) and side
chain signals arising from NH2-groups are connected by dotted lines.
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sequence. Overall, the influence of the myristoyl moiety is quiet strong.
Nearly half of the signals (46.4%) change their chemical shift by more
than 0.02 ppm and a change in chemical shift of more than 0.04 ppm
is observed for 27.3% of the signals. The most significant chemical shift
change is observed for Thr58. The mean chemical shift difference for all
assigned residues is 0.03 ppm. Nevertheless, the influence of the
myristoyl moiety on the GCAP-2 chemical shifts is not evenly distribut-
ed. The presence or absence of the myristoyl chain shows the main
structural influence in the N-terminal half of the protein at residues
44-58, at the end of the F-helix of the third EF hand and the followingloop region at residues 120-134, and near the C-terminus of the protein,
residues 175 – 194 (see Fig. 3).
3.3. Influence of CHAPS on the structure of myristoylated and
non-myristoylated GCAP-2
GCAP-2 has a tendency to formoligomers at high concentration [39],
which renders solution-state NMR spectroscopy difficult because the
higher molecular weight and the dynamic equilibrium between the
different oligomeric states cause a substantial signal broadening.
Ames et al. used 25 mM octyl-β-D-glucopyranosid to prevent oligomer
Fig. 2. Secondary structure of myristoylated GCAP-2 (in the presence of 10 mM CHAPS) based on the backbone chemical shifts (Cα, C’, NH, HN) as predicted by TALOS+. A secondary
structure prediction value of 1 means α-helical, -1 refers to β-strand and a score around 0 indicates a random-coil conformation. For comparison, the secondary structure of Ca2+-
bound non-myristoylated GCAP-2 according to literature is depicted above the graph [19]. Random-coil structures are depicted as lines, α-helices as cylinders and β-strands as arrows;
the flexible loop, as a main difference to GCAP-1, is also highlighted. The different EF hand motives were consecutively color coded (EF-1: green, EF-2: red, EF-3: violet, EF-4: yellow).
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solve the structure of non-myristoylatedGCAP-2 [40]. Formyristoylated
GCAP-2, octyl-β-D-glucopyranosid had not such a positive effect on the
NMR spectra (data not shown), however, a significant improvement of
theNMR spectra could be obtained in the presence of CHAPS. CHAPS is a
mild, non-denaturing detergent that prevents protein-protein interac-
tions and therefore suppresses oligomerization [40,41]. CHAPS was
also used for NMR investigations on the related protein recoverin [42].
Because our assignment of the myristoylated form of GCAP-2 was alsoFig. 3.Weighted chemical shift differences Δδ between themyristoylated and the non-myristoy
the absence of detergent or lipid. For comparison, the secondary structure of Ca2+-bound non-mdone in the presence of CHAPS, we investigated the structural influence
of CHAPS on the myristoylated as well as on the non-myristoylated
form. 1H-15NHSQC spectra of both forms of theprotein show significant
differences for varying CHAPS concentrations (Fig. S2). Fig. 4 shows the
weighted chemical shift difference Δδ along the protein amino acid
sequence during the CHAPS titration for the myristoylated form of
GCAP-2. For comparison, the chemical shift perturbations upon CHAPS
addition of the non-myristoylated form of GCAP-2 is shown in Fig. S3.
Overall, the influence of CHAPS on the myristoylated form (Fig. 4) islated forms of GCAP-2 as a measure for the structural influence of the myristoyl moiety in
yristoylated GCAP-2 according to literature is depicted schematically above the graph [19].
Fig. 4. Influence of increasing CHAPS concentration on the weighted chemical shift differencesΔδ of myristoylated GCAP-2, measured in the 1H-15 N HSQC spectra as a function of CHAPS
concentration. For comparison, the secondary structure of Ca2+-bound non-myristoylated GCAP-2 according to literature is depicted schematically above the graph [19].
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ety, but as the dispersion of the signals in 1H-15 NHSQC spectra (Fig. S2)
shows, it is clearly not denaturing the protein. However, quite strong
chemical shift changes are observed. For 74.4% of the signals, the chem-
ical shifts changes more than 0.02 ppm and almost half of the signals
(48.0%) shift by more than 0.04 ppm. The most significant chemical
shift change is observed for Gly38. The mean chemical shift difference
for all residues between the first and the last titration point is
0.06 ppm. Interestingly, most chemical shift alterations are observed
in the N-terminal half of the protein, while the C-terminal half only
shows moderate chemical shift changes except for the terminal ~20
amino acids. This pattern is particularly pronounced for the
myristoylated form of GCAP-2. Interestingly, a similar pattern of influ-
enced amino acids was observed for the comparison of the
myristoylated and non-myristoylated forms of the protein, in particular
for theN-terminal half of themolecule (Fig. 3). Only the influence at the
F-helix of the third EF-hand is far less pronounced compared to the in-
fluence of the myristoyl moiety onto the same region (see Fig. 3).
CHAPS also caused a structural influence on the non-myristoylated
form (Fig. S3). Again, a similar distribution of influenced amino acids
is observed, but overall the chemical shift changes are less pronounced.
To determine the myristoylation specific effect of CHAPS, we calculated
the absolute difference (ΔΔδ) between the weighted chemical shift dif-
ference of the myristoylated and non-myristoylated form: ΔΔδ =
|Δδmyr.− Δδnon − myr.|. The result is shown in Fig. S4. Themyristoylation
specific influence of CHAPS shows a similar pattern as observed for
attaching the myristoyl moiety. Moreover the strength of the effect is
also comparable.
3.4. Influence of DPC on the structure of myristoylated and
non-myristoylated GCAP-2
Because CHAPS does not represent a goodmembranemimicking de-
tergent [43], in the next step, we tested the structural influence of DPC
micelles on GCAP-2. DPC forms micelles that provide surfaces, whichbetter resemble those of phospholipid membranes than CHAPS. DPC
features a physiological phosphocholine head group as one of the
main phospholipids of the cellular membrane and it is widely used in
solution-state NMR investigations on membrane proteins [44].
The 1H-15 N HSQC spectra of myristoylated GCAP-2 in the absence
and presence of 40 mM DPC are shown in Fig. S5. As a general impres-
sion, the chemical shift dispersion of the NMR signals is markedly re-
duced in the presence of 40 mM DPC. As a consequence, only ~37% of
the signals could be assigned. The weighted chemical shift differences
Δδ along the protein amino acid sequence as a function of increasing
DPC concentrations for the myristoylated GCAP-2 is shown in Fig. 5.
As seen from these titrations, DPC causes very strong effects, especially
at higher concentrations (N5 mM). In contrast to the CHAPS titration,
the influence of DPC appears to extendover the entire protein sequence.
The mean chemical shift difference for all residues is 0.17 ppm. As the
dispersion of the 1H-15 N HSQC signals shows (see Fig. S5), DPC has a
denaturing effect on GCAP-2. It is a bit surprising that we observed
such an effect for DPC here, which is known to be a relatively well-
suited membrane mimicking detergent. The denaturing effect, we ob-
served could be related to the fact that GCAP is not a membrane protein
with stable transmembrane segments, but rather a relatively unstable
soluble protein, that may get more unstable in the presence of the
DPC surfaces.
3.5. Influence of bicelles on the structure of myristoylated and
non-myristoylated GCAP-2
Finally, we investigated the structural changes upon binding of
myristoylated GCAP-2 on DMPC/DHPC bicelles (q = 0.25), as the
most membrane-like structure applicable to solution-state NMR.
Fig. S6 shows the superposition of the 1H-15 N HSQC spectra in the ab-
sence and in the presence of bicelles (10 mM DMPC / 40 mM DHPC).
While there are significant chemical shift changes, the overall chemical
shift dispersion remains comparable in the presence and in the absence
of DMPC/DHPC bicelles. In Fig. 6, the weighted chemical shift difference
Fig. 5. Influence of DPC on myristoylated GCAP-2, measured as the weighted chemical shift difference Δδ in the 1H-15 N HSQC spectra. For comparison, the secondary structure of Ca2+-
bound non-myristoylated GCAP-2 is depicted schematically above the graph [19].
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DMPC/DHPC bicelles cause a weaker effect then CHAPS and DPC. The
mean chemical shift difference between the first and the last titration
point is 0.04 ppm at the largest bicelle concentration. Nevertheless,
DMPC/DHPC bicelles cause a structural effect with a similar pattern as
CHAPS, so the main chemical shift alterations are observed in the
N-terminal half of the protein, the F-helix of the third EF-hand, and
near the C-terminus (see Fig. 6). Compared to the effect of themyristoyl
moiety alone (see Fig. 3), bicelles cause amore pronounced (nearly dou-
bled) and wider but more evenly distributed effect in the N-terminal
half of the protein, at the F-helix of the third EF-hand, and near the C-
terminus the effect is of comparable strength. Compared with the effect
of CHAPS on themyristoylated form, the effect on the N-terminal region
is wider, more evenly distributed but comparable in strength. The effect
at the F-helix of the third EF-hand has, in the case of bicelles, a broader
distribution and is slightly stronger; at the C-terminus the distribution is
again broader but also weaker compared to the effect of CHAPS.Fig. 6. Influence of DMPC/DHPC bicelles (q = 0.25) on myristoylated GCAP-2, measured as th
secondary structure of Ca2+-bound non-myristoylated GCAP-2 is depicted schematically above3.6. CS-ROSETTA homology model of myristoylated, Ca2+-bound GCAP-2
We calculated a homologymodel formyristoylated GCAP-2 (Fig. 7b)
based on themeasured backbone chemical shifts (HN, NH, C’ and Cα) for
myristoylated GCAP-2 in the absence of membranemimetics and based
on the crystal structure of myristoylated, Ca2+-bound GCAP-1. The
RMSD of Cα back bone atom positions compared to the best scored
model vs. the CS-ROSETTA score of each model is shown in Fig S7. The
calculations based on the chemical shifts converged to a cluster with a
radius of about 3 Å. At this point, it should be mentioned, that this spe-
cial case of a myristoylated, Ca2+ binding protein poses a major chal-
lenge to CS-ROSETTA. Despite the fact that it is not a small protein
(203 amino acids) and it is predominantlyα-helical, themain challenge
in the CS-ROSETTA protocol is accurate chemical shift prediction. To our
knowledge no chemical shift prediction algorithm accounts for the
chemical shift influences caused by the positive charges of the Ca2+
ions or even by the hydrophobicity of the myristic acid itself. Thise weighted chemical shift difference Δδ in the 1H-15 N HSQC spectra. For comparison, the
the graph [19].
Fig. 7. Visualization of the observed 1H and 15 N chemical shift changes between myristoylated and non-myristoylated GCAP-2 mapped onto the available NMR structure of non-
myristoylated GCAP-2 (a) (PDB ID: 1JBA, [19]) and our CS-ROSETTA homology model of myristoylated GCAP-2 (b) based on the crystal structure of myristoylated GCAP-1 (PDB ID:
2R2I, [20]) and the measured backbone chemical shifts of myristoylated GCAP-2. A close-up look into the hydrophobic pocket, accommodating the myristoyl moiety is given in
panel (c). Theweighted chemical shift differences are linearly color coded in red, given relative to themaximal found chemical shift difference. Bound Ca2+ ions are not shown for clarity.
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shifts which will be reflected in a wider and possibly biased structural
ensemble. Consequently, the agreement between predicted and
experimental chemical shift can be improved when ignoring the EF
hand residues when scoring chemical shift agreement. As a result the
structural ensemble gets more focused as expressed by a reduction in
average RMSD to the best scoring model (see Fig. S7). Therefore, to cal-
culate a structure of myristoylated, Ca2+-bound GCAP-2 from chemical
shifts only represents a major challenge. Nevertheless, Fig. S7 shows a
convergence of the calculations and the best scored structure can be
used as a first model of myristoylated, Ca2+ bound GCAP-2.
The calculated model showed some interesting features. First, the
myristic moiety is locked into an N-terminal hydrophobic pocket. The
relevant side chains that were found to interact with myristic acid in
the crystal structure of GCAP-1 are also in close contact with the
myristic acid in thismodel. The F-helix of the 3rd EF-hand is still bended
but not kinked as much as in the crystal structure of GCAP-1 but more
than in the crystal structure of non-myristoylated GCAP-3. The
C-terminus, although loop modeled, contains an α-helix which again
forms an important part of the myristoyl moiety binding pocket.
4. Discussion
While protein lipid modifications are classical membrane anchors
[45], experimental results have so far not unambiguously explained
the role of the N-myristoylation of GCAP-2. The most troublesomeexperimental observation is the fact that themembrane binding energy
for myristoylated and non-myristoylated GCAP-2 is approximately the
same [22] while thorough thermodynamic considerations [23] one
would predict a difference in ΔG0 of about -30 kJ/mol between the
two forms of the protein, which was clearly not observed. This would
allow the conclusion that themyristoylmoiety of GCAP-2 does not func-
tion as a membrane anchor. Such a scenario would be in agreement
with the crystal structure of GCAP-1 [20], which showed that the
myristoyl chain is buriedwithin the protein to exert a structure stabiliz-
ing function [46]. In contrast, 2H NMR results have clearly shown that
the myristoyl moiety is membrane inserted when GCAP-2 is bound to
lipid bilayers [27]. This seems to suggest that in the absence of any
membranes, themyristoyl moiety of GCAP-2 could indeed be buried in-
side the protein but is released from the protein interior and inserted
into themembranewhen the protein senses the low dielectric constant
environment of the bilayer surface. It has also been suggested that the
membrane orientation of the myristoylated and non-myristoylated
protein may be different giving rise to the low differences in ΔG0 for
membrane binding of GCAP-2 in the presence or absence of the
myristoyl anchor [27]. Nevertheless, a myristoyl switch of some kind
would be required for such amodel and the goal of this study was to in-
vestigate what structural alterations accompany the transfer of GCAP-2
from the aqueous state to the membrane bound conformation. To this
end, we determined a structural model of myristoylated GCAP-2 on
the basis of NMR chemical shifts in solution and investigated (i) struc-
tural differences between the myristoylated and non-myristoylated
2775A. Margetić et al. / Biochimica et Biophysica Acta 1838 (2014) 2767–2777GCAP-2 in solution and (ii) structural changes of the protein in the pres-
ence of detergents and membrane mimetics by solution state NMR
spectroscopy.
4.1. Structural differences between the myristoylated and
non-myristoylated GCAP-2
The presence and absence of themyristoyl chain on GCAP-2 showed
significant chemical shift changes in the protein that are mostly local-
ized in the first and second EF hands, the F helix of the third EF hand,
the beginning of the loop to the fourth EF hand, and the C-terminal
end of the protein (Fig. 3). However, as the TALOS + analysis has
shown, the presence or absence of themyristoyl moiety has no relevant
influence on the general secondary structure of GCAP-2. The observed
changes could be attributed to either local effects or also more global
tertiary structure changes of the protein. This particularly concerns the
N-terminal half of the molecule. These chemical shift differences be-
tween the myristoylated and non-myristoylated forms of the protein
are unlikely to stem from a water exposed myristoyl chain attached to
the flexible N-terminus. Therefore, our results are in agreement with
the localization of themyristoylmoiety inside theprotein in the absence
of any membrane or membrane mimic. This can be rationalized by
comparison with literature data: the FCaBP is a protein with a solvent
exposed myristoyl moiety and the 1H-15 N HSQC spectra of the
myristoylated form and the non-myristoylated form show virtually no
differences [47]. Therefore, the rather drastic chemical shift changes ob-
served for GCAP-2 suggest that the myristoyl moiety of GCAP-2 should
be bound to the protein in a surface pocket or buried inside the hydro-
phobic core of the molecule.
To understand the localization of the myristoyl chain in relation to
the observed chemical shift changes,wemap the chemical shift changes
onto the 3D structure of non-myristoylated GCAP-2 and onto the
CS-ROSETTA model of myristoylated GCAP-2 (see 3.6, Fig. 7a and b). It
can be seen, that themyristoylmoiety of GCAP-2 localizes in a hydropho-
bic pocket in the N-terminal part of the protein forming close contact to
mostly the same amino acids, which constitute the hydrophobicmyristic
acid binding pocket in the crystal structure of GCAP-1 [20]. Stephen et al.
indentified a set of hydrophobic and aromatic amino acids in close con-
tact to the myristoyl moiety [20]. Indeed, the same residues display
strong chemical shift differences caused by the myristoyl moiety in
GCAP-2, in the cases where unambiguous assignment transfer was pos-
sible and (see Fig. 7c). Furthermore, the authors emphasize the impor-
tant role of the C-terminal helix of GCAP-1 for the binding pocket for
themyristoylmoiety [20]. Indeed,we alsofind strong chemical shifts dif-
ferences in this part caused by the myristoyl moiety and the model of
myristoylated GCAP-2 also suggests that the C-terminal helix is part of
the myristic acid binding pocket. Most likely the myristoyl moiety of
free GCAP-2 is bound to the protein and buried inside a hydrophobic
pocket similar to the arrangement shown in the crystal structure of
GCAP-1.
Interestingly, one of themajor influences of themyristoyl moiety on
the structure of GCAP-2 is found in the F-helix of the third EF-hand, and
compared to the solution-NMR structure of non-myristoylated GCAP-2,
the CS-ROSETTAmodel ofmyristoylated GCAP-2 shows that this helix is
bent, additionally this helix is strongly kinked in the crystal structure of
myristoylated GCAP-1, but straight in the crystal structure of non-
myristoylated GCAP-3. This raises the question, if the kink is caused by
the myristoylation and if it also exists in myristoylated GCAP-2. The
kink is localized around residue Ile123, and indeed, this region shows
significant chemical shift changes (see Fig. 3). Thus, it is plausible that
the presence of the myristoylation also induces a structural change in
F-helix of the third EF-hand. We have tried to determine chain NOEs
in that region; however, given the very crowded situation of the pre-
dominantlyα-helical protein (see Fig. 1), it was in our hands not possi-
ble to assign a sufficient amount of side chain signals for a detailed NOE
analysis. Therefore, without further structural data, we cannotsubstantiate structural details of any conformational change in this re-
gion. Kollmann et al. [48] investigated the effect of myristoylation and
Ca2+ binding onto the fluorescence lifetime and rotational anisotropy
of the fluorescence dye Alexa647 attached to Cys111 (at the beginning
of the F-helix of the third EF-hand) and Cys131 (at the end of the
F-helix of the third EF-hand) of GCAP-2. In agreement with our data,
they also found an influence of the myristoylation onto this part of the
protein.
The observed chemical shift differences between the myristoylated
andnon-myristoylated formsof GCAP-2 also suggest a second structural
change to occur in the beginning of the E-helix of the second EF hand.
While the NMR structure of non-myristoylated GCAP-2 shows this re-
gion relatively poorly structured with a kink in the helix, in the crystal
structure of GCAP-1 this helix is straight and well structured. Indeed,
we find the largest chemical shift change exactly in this region (around
Thr58), suggesting that the addition of the myristoyl moiety leads to a
structuring of this region as the homology model suggests.
Taken together, the chemical shift data suggest that the addition of
the myristoyl chain to GCAP-2 leads to significant structural alterations
and the chemical shift changes observed are in agreement with a
conformation, where the myristoyl moiety is buried inside the protein
similar to the crystal structure of GCAP-1 [20].
4.2. Structural changes of GCAP-2 upon binding to lipophilic surfaces
To reconcile this structural model with the previous experimental
observation that the myristoyl chain of GCAP-2 is bilayer inserted
when the protein is bound to lipid membranes, we investigated struc-
tural changes in themyristoylated protein in the presence ofmembrane
mimetics CHAPS micelles, DPC micelles, and DMPC/DHPC bicelles.
While the chemical shift differences and the accompanied structural
changes of myristoylated GCAP-2 caused by CHAPS micelles and
DMPC/DHPC bicelles showed a clear pattern, the presence of DPC mi-
celles lead to rather homogeneous chemical shift changes. This suggests
that the structural changes caused by DPC micelles are more or less
evenly distributed along the entire protein sequence. This strong effect
of DPC on the GCAP-2 structure is apparently caused by the denaturing
effect of this detergent, which could be seen by the loss of signal disper-
sion in the 1H-15 NHSQC spectra during theDPC titration (see Fig. S5). In
contrast, CHAPS micelles and DMPC/DHPC bicelles induced strong
chemical shift alterations of GCAP-2 following a clear pattern and
evidently no denaturing effect was observed.
To visualize the changes caused by CHAPSmicelles and DMPC/DHPC
bicelles we again plot the chemical shift changes caused by those agents
onto the CS-ROSETTAmodel ofmyristoylatedGCAP-2 as shown in Fig. 8.
The protein structure changes, due to the interaction with these
membrane mimics, mostly in the N-terminal part, but also at the
C-terminus and in the F-helix of the third EF-hand.
It should be noted that the chemical shift changes caused by the
membrane mimetics does not resemble the reversed effect caused by
the intrusion of the myristoyl moiety into the hydrophobic pocket. But
it cannot be ignored that all variations of the environment cause chem-
ical shift changes not only the differences in the localization of the
myristoyl group but also the increasing amount of detergent or bicelles
in the sample. Furthermore, after binding, some of the influenced resi-
dues may experience even stronger chemical shift change then others,
due to thehigher local concentration of lipids or because they are direct-
ly involved in the binding action.
However, the patterns of chemical shift changes very closely resem-
ble the chemical shift differences between myristoylated and non-
myristoylated GCAP-2. It is therefore tempting to suggest that these
chemical shift changes indicate the translocation of the myristoyl
moiety from the protein interior into the hydrophobic environment of
the membrane mimetic. This can explain why the myristoyl chain of
GCAP-2 is always found membrane embedded in membrane-associated
GCAP-2 [22,27,38]. Such a scenario could be interpreted as a myristoyl
Fig. 8. Visualization of the influence of CHAPS micelles (20 mM CHAPS) (a) and DMPC/
DHPC bicelles (10 mM DMPC / 40 mM DHPC) (b) on the observed 1H and 15 N chemical
shift changes of myristoylated GCAP-2. The chemical shift changes are linearly color
coded in red mapped onto our CS-ROSETTA homology model of myristoylated GCAP-2
based on the crystal structure of myristoylated GCAP-1 (PDB ID: 2R2I, [20]) and the mea-
sured backbone chemical shifts of myristoylated GCAP-2. Bound Ca2+ ions are not shown
for clarity.
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structures.
For both CHAPS micelles and DMPC/DHPC bicelles, the biggest
chemical shift difference experiences Gly38, which is located in the
loop region of the 1st EF-hand. Due to a Cys-Pro sequence, the first EF-
hand is not able to bind Ca2+ [19]. Because glycine lacks a sterically
hindering side chain, it can easily adopt different backbone torsion
angles [49], therefore, one can speculate if it may serve as hinge for
the myristoyl moiety switch mechanism.
5. Conclusions
Themyristoyl moiety of GCAP-2 causes significant structural changes
of the protein. All NMR results obtained here support the view that themyristoyl moiety is buried inside the protein in the absence of mem-
branes ormicelles as depicted in Figs. 7 and 8. The titration of CHAPSmi-
celles and DMPC/DHPC bicelles cause chemical shift differences in the
same regions of the protein, which also differ between themyristoylated
and non-myristoylated forms of GCAP-2. Therefore, it is plausible that
the presence ofmembranes ormicelles induces a conformational switch,
which causes the myristoyl chain to be released from the hydrophobic
protein interior to insert into the hydrophobic core of the membrane
without much change in the free energy. Such a model would be in
agreement with the experimental observations that (i) the myristoyl
chain is always foundmembrane inserted in the presence ofmembranes
[27], and (ii) no major differences in ΔG0 are observed for membrane
binding of myristoylated and non-myristoylated GCAP-2 [22].Acknowledgements
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